No Data
Analysts Have Lowered Expectations For Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) After Its Latest Results
ShenZhen New Industries Biomedical Engineering (300832.SZ): This adjustment in the USA tariff policy has a relatively limited direct impact on the company's overseas Business.
On April 8, Gelonghui reported that ShenZhen New Industries Biomedical Engineering (300832.SZ) stated on the investor interaction platform that the company has determined the direct impact of the recent USA tariff policy adjustment on its overseas Business is relatively limited. By region, the company's Business growth performance in Europe and Latin America for 2024 is outstanding, while revenue from the USA accounts for less than 0.1% of overseas revenue. The company will insist on technology innovation as its core competitive advantage. Regardless of how the external environment changes, the company will continue to launch more competitive products to meet the needs of clinical end-users and increase market share. The company will continue to adhere to deepening efforts in overseas markets.
ShenZhen New Industries Biomedical Engineering (300832.SZ) performance report: For the fiscal year 2024, the net income attributable to the parent company is 1.828 billion yuan, representing a year-on-year growth of 10.57%.
On April 8, Gelonghui reported that ShenZhen New Industries Biomedical Engineering (300832.SZ) announced its performance quick report for the year 2024. In 2024, the company achieved revenue of 4.535 billion yuan, a year-on-year increase of 15.41%; total profit of 2.093 billion yuan, a year-on-year increase of 10.57%; net income attributable to shareholders of the listed company of 1.828 billion yuan, a year-on-year increase of 10.57%; net income attributable to shareholders of the listed company after excluding non-recurring gains and losses of 1.72 billion yuan, a year-on-year increase of 11.19%; and basic EPS of 2.3271 yuan/share.
Express News | New Industries Biomedical Prelim 2024 Net Profit up 10.6% Y/Y
New Industries: 2024 Annual Results Report Announcement
ShenZhen New Industries Biomedical Engineering (300832.SZ) has received IVDR CE certification for multiple products.
ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that 73 of its products have been certified by the EU notification body - TÜV SÜD...
Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Share Price Not Quite Adding Up
